Gan & Lee Pharmaceuticals. (603087.SS) SHH
54.74
-0.25(-0.45%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Gan & Lee Pharmaceuticals.
Address
No. 8, Nanfeng West 1st Street
Beijing, 101109
China
Phone
86 10 8059 3699
Website
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Employees
4482
First IPO Date
June 29, 2020
Key Executives
| Name | Title | Pay | Year Born |
| Weiqiang Song | Deputy GM & Director | 0 | 1982 |
| Zifei Yuan | Deputy General Manager | 0 | 1989 |
| Li Zhou | Head of Accounting | 0 | N/A |
| Kai Du | GM & Director | 0 | 1977 |
| Zhongru Gan | Founder & Chairman | 0 | 1948 |
| Jiaxin Wang | Supervisor & Archives Manager | 0 | 1993 |
| Rong Zou | Secretary | 0 | 1983 |
| Yajuan Feng | Head of Administrative Department & Supervisor | 0 | 1992 |
| John Wang | Senior VP & Chief Strategy Officer | 0 | 1961 |
| Ting Jia | Chief Medical Officer | 0 | N/A |
| Qianming Wang | Chief Financial Officer | 0 | N/A |
| Zijia Chen | Brand Public Relations Manager | 0 | N/A |
| Zhi Li | Deputy General Manager | 0 | 1993 |
| Cheng Xing | Deputy General Manager | 0 | 1991 |
| Wei Chen | Deputy GM & Director | 0 | 1980 |
| Cheng Sun | Chief Financial Officer & Deputy GM | 0 | 1979 |
Description
Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the research, development, production, and commercialization insulin analogues primarily in China. Its products include Basalin, an insulin glargine injection; Prandilin, an insulin lispro injection; Prandilin 25, an insulin lispro; Raplin, an insulin aspart injection; Raplin 30, an insulin aspart 30 injection; and Similin 30, an insulin injection, as well as medical devices. The company was formerly known as Beijing Gan & Lee Biotechnology Co., Ltd. and changed its name to Gan & Lee Pharmaceuticals. in April 2005. Gan & Lee Pharmaceuticals. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
